Malaysia · Delayed Price · Currency is MYR LAC Med Berhad Statistics
Total Valuation
LAC Med Berhad has a market cap or net worth of MYR 288.00 million. The enterprise value is 258.79 million.
| Market Cap | 288.00M |
| Enterprise Value | 258.79M |
Important Dates
The next estimated earnings date is Thursday, November 19, 2026.
| Earnings Date | Nov 19, 2026 |
| Ex-Dividend Date | May 26, 2026 |
Share Statistics
LAC Med Berhad has 400.00 million shares outstanding. The number of shares has decreased by -41.96% in one year.
| Current Share Class | 400.00M |
| Shares Outstanding | 400.00M |
| Shares Change (YoY) | -41.96% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 77.08% |
| Owned by Institutions (%) | 9.88% |
| Float | 88.19M |
Valuation Ratios
The trailing PE ratio is 4.61 and the forward PE ratio is 10.29.
| PE Ratio | 4.61 |
| Forward PE | 10.29 |
| PS Ratio | 1.59 |
| PB Ratio | 2.35 |
| P/TBV Ratio | 2.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 14.21 |
| EV / Sales | 1.42 |
| EV / EBITDA | 9.50 |
| EV / EBIT | 10.51 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.32.
| Current Ratio | 2.12 |
| Quick Ratio | 1.80 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 1.46 |
| Debt / FCF | -1.16 |
| Interest Coverage | 21.37 |
Financial Efficiency
Return on equity (ROE) is 20.69% and return on invested capital (ROIC) is 20.51%.
| Return on Equity (ROE) | 20.69% |
| Return on Assets (ROA) | 8.88% |
| Return on Invested Capital (ROIC) | 20.51% |
| Return on Capital Employed (ROCE) | 19.15% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.82M |
| Profits Per Employee | 182,081 |
| Employee Count | 100 |
| Asset Turnover | 1.05 |
| Inventory Turnover | 4.93 |
Taxes
In the past 12 months, LAC Med Berhad has paid 7.03 million in taxes.
| Income Tax | 7.03M |
| Effective Tax Rate | 27.95% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.75 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 37.96 |
| Average Volume (20 Days) | 332,450 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LAC Med Berhad had revenue of MYR 181.67 million and earned 18.21 million in profits. Earnings per share was 0.16.
| Revenue | 181.67M |
| Gross Profit | 50.37M |
| Operating Income | 24.62M |
| Pretax Income | 25.17M |
| Net Income | 18.21M |
| EBITDA | 27.05M |
| EBIT | 24.62M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
The company has 68.99 million in cash and 39.77 million in debt, with a net cash position of 29.22 million or 0.07 per share.
| Cash & Cash Equivalents | 68.99M |
| Total Debt | 39.77M |
| Net Cash | 29.22M |
| Net Cash Per Share | 0.07 |
| Equity (Book Value) | 122.50M |
| Book Value Per Share | 0.31 |
| Working Capital | 111.71M |
Cash Flow
In the last 12 months, operating cash flow was -23.71 million and capital expenditures -10.55 million, giving a free cash flow of -34.26 million.
| Operating Cash Flow | -23.71M |
| Capital Expenditures | -10.55M |
| Depreciation & Amortization | 2.43M |
| Net Borrowing | 23.76M |
| Free Cash Flow | -34.26M |
| FCF Per Share | -0.09 |
Margins
Gross margin is 27.73%, with operating and profit margins of 13.55% and 10.02%.
| Gross Margin | 27.73% |
| Operating Margin | 13.55% |
| Pretax Margin | 13.85% |
| Profit Margin | 10.02% |
| EBITDA Margin | 14.89% |
| EBIT Margin | 13.55% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.90%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.90% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 41.74% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 41.96% |
| Shareholder Yield | 42.86% |
| Earnings Yield | 6.32% |
| FCF Yield | -11.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LAC Med Berhad has an Altman Z-Score of 4.17 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.17 |
| Piotroski F-Score | 5 |